p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene
- PMID: 9377555
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene
Abstract
Hypoxia-induced neovascularization mediated by vascular endothelial growth factor (VEGF) contributes to tumor progression. Based on its effects when overexpressed in transient transfection assays, p53 has been proposed to repress VEGF transcription. To investigate this hypothesis, we have analyzed endogenous VEGF mRNA levels in Hep3B cells stably expressing an inducible p53-estrogen receptor fusion protein and in irradiated RKO cells expressing endogenous wild-type p53. In both cell lines, VEGF mRNA levels increased in response to hypoxia, either in the presence or absence of functional p53. Our data provide no evidence for a causal relationship between the loss of p53 activity and increased VEGF expression that is observed during tumor progression. Studies that attribute repressor functions to p53 based on analysis of cells transiently overexpressing this protein should be interpreted cautiously.
Similar articles
-
Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.Cancer Res. 2001 Sep 15;61(18):6952-7. Cancer Res. 2001. PMID: 11559575
-
V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.Cancer Res. 1997 Dec 1;57(23):5328-35. Cancer Res. 1997. PMID: 9393757
-
Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.Anticancer Res. 2002 Sep-Oct;22(5):2697-702. Anticancer Res. 2002. PMID: 12529984
-
Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.Cancer Res. 2000 Jul 1;60(13):3655-61. Cancer Res. 2000. PMID: 10910082
-
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.Oncogene. 2002 Apr 25;21(18):2896-900. doi: 10.1038/sj.onc.1205382. Oncogene. 2002. PMID: 11973650
Cited by
-
Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.World J Gastroenterol. 2000 Aug;6(4):565-568. doi: 10.3748/wjg.v6.i4.565. World J Gastroenterol. 2000. PMID: 11819648 Free PMC article. No abstract available.
-
2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.Neoplasia. 2003 Sep-Oct;5(5):417-26. doi: 10.1016/s1476-5586(03)80044-1. Neoplasia. 2003. PMID: 14670179 Free PMC article.
-
VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells.Hum Cell. 2003 Mar;16(1):47-54. doi: 10.1111/j.1749-0774.2003.tb00128.x. Hum Cell. 2003. PMID: 12971625
-
p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway.Cell Death Differ. 2013 Jul;20(7):888-97. doi: 10.1038/cdd.2013.12. Epub 2013 Mar 1. Cell Death Differ. 2013. PMID: 23449391 Free PMC article.
-
DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.Mol Cell Biol. 2004 Jul;24(13):5757-66. doi: 10.1128/MCB.24.13.5757-5766.2004. Mol Cell Biol. 2004. PMID: 15199132 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous